Cryptic infertility and therapeutic options

Clinical and Experimental Obstetrics and Gynecology

Volumn 28, Issue 4, 2001, Pages 205-211

  Check, Jerome H ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; PROGESTERONE;

EMBRYO TRANSFER; ENDOMETRIOSIS; ENDOMETRIUM ATROPHY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYSTEROSALPINGOGRAPHY; IATROGENIC DISEASE; LAPAROSCOPIC SURGERY; LUTEINIZATION; MENSTRUAL CYCLE; OVARY FOLLICLE; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVULATION; POSTCOITAL TEST; REVIEW; SEMEN ANALYSIS;

FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; LUTEAL PHASE; MALE; OVULATION; SPERMATOZOA;

EID: 0035712837     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. An evaluation of etiologic factors and therapy in 555 private patients with primary infertility
2. Luteal phase in infertility: Problems of evaluation
3. Diagnostic test properties of serum progesterone in the evaluation of luteal phase defects
4. The role of progesterone in supporting implantation and preventing early pregnancy loss
5. Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis
6. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation
7. The efficacy of progesterone in achieving successful pregnancy: I. Prophylactic use during luteal phase in anovulatory women
8. Ovulation-inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects
9. Premature luteinization: Treatment and incidence in natural cycles
10. Follicular fluid steroid levels in dysmature and mature follicles from spontaneous and hyperstimulated cycles in normal and anovulatory women
11. Reduction in in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase
12. Preliminary report about a modified gonadotropin (human menopausal gonadotropin/human chorionic gonadotropin). Treatment in infertile patients with premature luteinization
13. Successful treatment of infertile women with oligomenorrhea using a combination of LHRH agonist and exogenous gonadotrophins
14. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression
15. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval
16. Comparison of short versus long-term leuprolide acetate-human menopausal gonadotrophin hyperstimulation in in-vitro fertilization patients
17. Ultrasonic evidence for luteinization of unruptured preovulatory follicles
18. Ultrasonic assessment of subsequent unexplained infertility after ovulation induction
19. New approaches to the diagnosis and therapy of the luteinized unruptured follicle syndrome
20. The luteinized unruptured follicle and other ovulatory dysfunctions
21. Pharmacologic production of luteinized unruptured follicles by prostaglandin synthetase inhibitors
22. Pelvic sonography can predict ovum release in gonadotrophin-treated patients as determined by pregnancy rate
23. Comparison of various therapies for the luteinized unruptured follicle syndrome
24. The efficacy of short-term gonadotrophin-releasing hormone agonists versus human chorionic gonadotrophin to enable oocyte release in gonadotrophin stimulated cycles
25. Embryo implantation after human in vitro fertilization: Importance of endometrial receptivity
26. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients
27. Evaluation of the mechanism for higher pregnancy rates in donor oocyte recipients by comparison of fresh with frozen embryo transfer pregnancy rates in a shared oocyte programme
28. Hydrosalpinx reduces in vitro fertilization/embryo transfer pregnancy rate
29. The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilization
30. Hydrosalpinges in in-vitro fertilization: An unfavorable prognostic feature
31. Low implantation rate after in vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography
32. Impaired implantation after in vitro fertilization treatment associated with hydrosalpinx
33. Deleterious effect of in vitro fertilization
34. Salpingectomy(ies) improves the pregnancy rate after IVF in patients with unilateral or bilateral hydrosalpinx
35. Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx
36. Salpingectomy improves in vitro fertilization outcome in patients with a hydrosalpinx: Blind victimization of the fallopian tube?
37. Hydrosalpinx et sterilite: Indications de la salpingectomie
38. The infertile patient with hydrosalpinges: IVF with or without salpingectomy?
39. Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization? A pilot prospective randomized study
40. Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx
41. Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer
42. Ovarian hyperstimulation can reduce uterine receptivity. A case report
43. A case report demonstrating that follicle maturing drugs may create an adverse uterine environment even when not used for controlled ovarian hyperstimulation
44. The adverse effect of controlled ovarian hyperstimulation (COH) on subsequent conception may be associated with the detection of a progesterone induced immunomodulatory protein shortly after embryo transfer (ET)
45. Salpingectomy for unilateral hydrosalpinx may improve in vivo fecundity
46. Development of an assay to assess the functional integrity of the human sperm membrane and its relationship to other semen characteristics
47. The hypoosmotic swelling test as a useful adjunct to the sperm analysis to predict fertility potential
48. The hypoosmotic swelling test and the sperm mucus penetration test in determining fertilization of the human oocyte
49. On the diagnostic value of the hypoosmotic sperm swelling test in an in vitro fertilization program
50. An evaluation of the hypoosmotic sperm selling test as a predictor of fertilizing capacity in vitro
51. Differential evaluation of human sperm hypoosmotic swelling test and its relationship with the outcome of in-vitro fertilization of human oocytes
52. Comparison between the hypoosmotic swelling test and morphology evaluation using strict criteria in predicting in vitro fertilization (IVF)
53. The value of motile density, strict morphology, and the hypoosmotic swelling test in in-vitro fertilization-embryo transfer
54. A comparative prospective study using matched samples to determine the influence of subnormal hypoosmotic test scores of spermatozoa on subsequent fertilization and pregnancy rates following in vitro fertilization
55. Evidence that sperm with low hypoosmotic swelling scores cause embryo implantation defects
56. Two methods of achieving pregnancies despite subnormal hypo-osmotic swelling test scores
57. In vitro fertilization with intracytoplasmic sperm injection is an effective therapy for male factor infertility related to subnormal hypo-osmotic swelling test scores
58. Some semen abnormalities may cause infertility by impairing implantation rather than fertilization
59. The sperm stress test: A novel test that predicts pregnancy in assisted reproductive technologies
60. Stability of the hypo-osmotic swelling test over time
61. Immunization as therapy for recurrent spontaneous abortion: A review and meta-analysis
62. A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters
63. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody
64. Enhancement of the expression of progesterone receptor on progesterone treated lymphocyte after immunotherapy in unexplained recurrent spontaneous abortion
65. Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis
66. Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction
67. The blocking effect of progesterone on lymphocyte responsiveness is receptor-mediated
68. Evidence that the expression of progesterone induced blocking factor by maternal T-lymphocytes is positively correlated with conception
69. Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF)
70. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes
71. Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women
72. Prognosis for sperm fertilizability: Analysis of different variables in men
73. Effect of antisperm antibodies on computerized semen analysis
74. Effect of antisperm antibodies on postcoital results and effect of intrauterine insemination on pregnancy outcome
75. The use of chymotrypsin/galactose to treat spermatozoa bound with anti-sperm antibodies prior to intra-uterine insemination
76. ICSI as an effective therapy for male factor with antisperm antibodies
77. Results of 55 intracytoplasmic sperm injection cycles in the treatment of male-immunological infertility
78. Treatment of severe male immunological infertility by intracytoplasmic sperm injection
79. Intracytoplasmic sperm injection for treating infertility associated with sperm autoimmunity
80. Higher success rate by intracytoplasmic sperm injection than by subzonal insemination: Report of a second series of 300 consecutive treatment cycles
81. The importance of laparoscopic coagulation of mild endometriosis in infertile women
82. CA 125 levels measured in different phases of the menstrual cycle in screening for endometriosis
83. Correlation of basal menses CA-125 levels and 6 month preg-nancy rates in women undergoing treatments for infertility without assisted reproductive methods